Middle-East and Africa Ischemic heart Disease market is increasing continuously. Prevention is by regular exercise, maintaining a healthy weight and not smoking. Fruits and vegetables are healthy for body and it decreases the risk of cardiovascular disease and death. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.
Get Sample @ https://www.marketresearchfuture.com/sample_request/2585 .
Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa.
Study Aim of Middle-East and Africa Ischemic heart Disease Market:
To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments. To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Ischemic heart Disease market. To provide country level analysis of the market with respect to the current market size and future prospective.
Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (US), HeartWare (U.S.), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai.
Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others. On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others.
Regional Analysis of Middle-East and Africa Ischemic heart Disease Market:
According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2585 .
Table of Content:
1. Report Prologue
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Middle-East and Africa Ischemic Heart Disease Market by Type
7. Middle-East and Africa Ischemic Heart Disease Market by Diagnosis
8. Middle-East and Africa Ischemic Heart Disease Market by Treatment Type
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312
- 1Avg Daily Vews
- 1 Day
- 1 Week
- 1 Month
- 2 Months
- 6 Months
- 1 Year